López-Camacho, César http://orcid.org/0000-0001-7932-2341
Abbink, Peter http://orcid.org/0000-0003-1978-088X
Larocca, Rafael A. http://orcid.org/0000-0002-9995-1804
Dejnirattisai, Wanwisa
Boyd, Michael
Badamchi-Zadeh, Alex
Wallace, Zoë R.
Doig, Jennifer
Velazquez, Ricardo Sanchez http://orcid.org/0000-0001-6716-442X
Neto, Roberto Dias Lins http://orcid.org/0000-0002-3983-8025
Coelho, Danilo F. http://orcid.org/0000-0002-1111-0825
Kim, Young Chan http://orcid.org/0000-0003-2847-9407
Donald, Claire L. http://orcid.org/0000-0002-4370-0707
Owsianka, Ania
De Lorenzo, Giuditta
Kohl, Alain
Gilbert, Sarah C. http://orcid.org/0000-0002-6823-9750
Dorrell, Lucy
Mongkolsapaya, Juthathip
Patel, Arvind H. http://orcid.org/0000-0003-4600-2047
Screaton, Gavin R.
Barouch, Dan H.
Hill, Adrian V. S. http://orcid.org/0000-0003-0900-9629
Reyes-Sandoval, Arturo http://orcid.org/0000-0002-2648-1696
Funding for this research was provided by:
Innovate UK (972216)
Article History
Received: 11 January 2017
Accepted: 23 May 2018
First Online: 22 June 2018
Competing interests
: A.R.-S. and C.L.-C. are co-inventors of the Zika vaccines described in this manuscript, filed by Oxford University Innovation Limited in the International Patent Application No. PCT/GB2017/052220 Zika Vaccine; A.V.S.H. and S.C.G. are co-inventors on a patent application (WO/2012/172277) on the ChAdOx1 viral vector filed by Oxford University Innovation. The remaining authors declare no competing interests.